Dr. Martens

Corporate brand

British footwear brand known for durable air-cushioned boots, yellow welt stitching, and its association with music and youth subcultures.

Last updated November 4, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Dr. Martens is a British footwear and clothing brand whose products evolved from a practical comfort shoe into a globally recognized cultural symbol. The underlying design originated with German physician Klaus Märtens, who developed an air-cushioned sole after injuring his ankle while skiing in 1945. In 1947, Märtens entered into business with Herbert Funck in Germany. Their comfortable shoes initially found a particularly strong market among women, including older housewives, before attracting commercial interest outside Germany. British footwear manufacturer R. Griggs Group acquired the United Kingdom manufacturing rights in 1959. Griggs adapted the design for the British market, reshaped the heel, added the now-famous yellow stitching, and formalized the sole and construction features associated with the brand. The first British model, the cherry-red eight-eyelet 1460 boot, was introduced on 1 April 1960. The three-eyelet 1461 shoe followed in 1961. Their numerical names refer to their introduction dates, and both remain central products for the company. The early British customer base included postmen, police officers, factory workers, and other people seeking durable work footwear. From the late 1960s onward, the boots were adopted by skinheads and later by scooter riders, punks, new-wave musicians, goths, grunge followers, Britpop audiences, LGBT communities, and other youth and creative subcultures. This adoption gave Dr. Martens an identity associated with working-class pride, independence, rebellion, and self-expression. It also created an uncomfortable association with violent or far-right skinhead groups, although the brand has subsequently been embraced by a much broader range of communities. The business experienced severe difficulties in the late 1990s and early 2000s. In 2003, production at most British facilities ended and manufacturing moved largely to China and Thailand. The company later introduced a more comfortable product range and restarted limited production at its historic Cobbs Lane factory in Wollaston, Northamptonshire, for its premium Made in England or Vintage products. Manufacturing is now distributed across the United Kingdom, China, Vietnam, Laos, and Thailand. Permira acquired R. Griggs Group in 2013 for £300 million, after which the brand underwent a major restructuring and international expansion. Retail stores, clothing, bags, and other accessories were added to the traditional footwear business. A vegan footwear range launched in 2011 and became an important part of the brand's product development. In January 2021, Dr. Martens became a London Stock Exchange-listed company under ticker DOCS. Its global headquarters and design studio are in Camden Town, London, while its historic factory remains in Wollaston. Dr. Martens sells boots, shoes, sandals, clothing, bags, and accessories. The 1460 boot and 1461 shoe continue to account for a substantial share of brand sales, while collaborations and seasonal collections help connect the brand with contemporary fashion, music, entertainment, and streetwear audiences. The company remains active internationally and combines heritage manufacturing with larger-scale Asian production.

History

Klaus Märtens developed the original air-cushioned sole in Germany after a 1945 ankle injury. In 1947, he and Herbert Funck began producing shoes in Seeshaupt using molded discarded rubber. The design gained an initial following for comfort, particularly among women, and production expanded to Munich by 1952. In 1959, R. Griggs Group obtained British manufacturing rights. Griggs modified the heel, introduced yellow stitching, and marketed the product under the anglicized name Dr. Martens. The 1460 boot entered the British market on 1 April 1960, followed by the 1461 shoe in 1961. The products first served practical occupational needs, but their adoption by workers and later youth groups transformed them into cultural products. Skinheads adopted the boots in the late 1960s, followed by punks, scooter riders, new-wave musicians, goths, grunge consumers, Britpop audiences, and other subcultures. The brand became associated with music, anti-establishment style, and working-class identity. Its visibility also produced an association with violent or politically extremist skinhead groups, an aspect of the brand's history that coexists with its later use by diverse communities. The company expanded through licensed production and international distribution. In 1989, Accent Group became the first manufacturer of Dr. Martens outside the United Kingdom. By the 1990s, the brand was strongly linked to grunge and alternative fashion, and it operated a large store in London's Covent Garden. The business then entered a difficult period. In 2003, declining sales led to the closure of most UK manufacturing, with production moving mainly to Asia and more than 1,000 jobs lost. Limited British production resumed in 2004 for the Vintage line at the Cobbs Lane factory in Wollaston. A restructuring under CEO David Suddens helped stabilize the company. Retail expansion in the United Kingdom, United States, and Hong Kong accelerated from 2009, while clothing and vegan footwear broadened the offer. Permira acquired R. Griggs Group in 2013, and the brand continued to expand internationally under new management. The company retained its heritage products while developing sandals, accessories, collaborations, and contemporary materials. Dr. Martens was listed on the London Stock Exchange in January 2021. Today, the company operates as a global footwear and lifestyle brand. Its design studio and global headquarters are in Camden Town, London. Production takes place in the United Kingdom and several Asian countries, while the historic Northamptonshire factory continues to make a limited premium range. The 1460 and 1461 remain the brand's defining products, supported by a wider portfolio of footwear, apparel, bags, and accessories.

2025
Chief executive succession
[7]Dr. Martens CEO succession and first-half resultswwdjapan.com
Ije Nwokorie became chief executive officer, succeeding Kenny Wilson.
2021
London Stock Exchange listing
[1]Dr. Martensen.wikipedia.org
Dr. Martens became a publicly traded company on the London Stock Exchange under ticker DOCS.
2014
Permira acquisition
[12]Permira acquisitionnews.line.me
Permira-backed funds acquired the business from the Griggs family group.
2013
Permira acquires the brand owner
[1]Dr. Martensen.wikipedia.org
Permira acquired R. Griggs Group, the owner of Dr. Martens, in a reported £300 million transaction.
2011
Vegan line introduced
[1]Dr. Martensen.wikipedia.org
Dr. Martens launched footwear made with synthetic materials as an alternative to leather.
2004
Vintage production resumes in Wollaston
[1]Dr. Martensen.wikipedia.org
The brand restarted limited UK production for a range marketed as being made to original specifications.
2003
UK production largely ends
[1]Dr. Martensen.wikipedia.org
Most UK factories closed as the company responded to falling sales and shifted production mainly to China and Thailand.
2003
Most British factories close
[4]Dr. Martens Japanese Wikipedia articleja.wikipedia.org
Most United Kingdom production was closed and manufacturing shifted mainly to Asian facilities, while a Made in England range remained.
1989
First production outside the UK
[1]Dr. Martensen.wikipedia.org
Accent Group received rights to manufacture Dr. Martens in Dunedin, New Zealand.
1961
The 1461 shoe launches
[1]Dr. Martensen.wikipedia.org
The three-eyelet 1461 shoe was introduced one year after the 1460 boot. The three-eyelet 1461 became the brand’s second enduring core silhouette.
1960
The 1460 boot launches
[1]Dr. Martensen.wikipedia.org
The cherry-red eight-eyelet boot became the first major British Dr. Martens model and remains a core product.
1960
1460 boot launched in Britain
[4]Dr. Martens Japanese Wikipedia articleja.wikipedia.org
R. Griggs introduced the first British Dr. Martens boot, later known as the 1460.
1959
R. Griggs acquires UK rights
[1]Dr. Martensen.wikipedia.org
R. Griggs Group obtained the rights to manufacture and market the footwear in the United Kingdom.
1947
Märtens and Funck begin production
[1]Dr. Martensen.wikipedia.org
Klaus Märtens and Herbert Funck formed a footwear business in Germany and began selling shoes using the air-cushioned design.
1947
German production begins
[4]Dr. Martens Japanese Wikipedia articleja.wikipedia.org
Märtens and Herbert Funck began producing the footwear design in Germany.
1945
Klaus Märtens develops the air-cushioned sole
[1]Dr. Martensen.wikipedia.org
After injuring his ankle, German physician Klaus Märtens designed a more comfortable boot sole using air cushioning.
1945
Air-cushioned sole concept developed
[4]Dr. Martens Japanese Wikipedia articleja.wikipedia.org
Klaus Märtens designed a softer, air-cushioned sole after injuring his foot while skiing.

Products and positioning

Premium, expressive footwear and lifestyle apparel centered on durability, recognizable British heritage, individualism, and rebellious cultural identity. Heritage footwear combining durability, air-cushioned comfort, recognizable design, and cultural self-expression.

Boots · 1960
1460
The 1460 is the signature eight-eyelet Dr. Martens boot, originally introduced in cherry-red smooth leather on 1 April 1960. It is distinguished by an air-cushioned sole, welted construction, yellow stitching, a pull tab, grooved sole edge, and a durable rounded upper. The model has been repeatedly reinterpreted in different leathers, colors, prints, collaborations, and vegan materials while retaining its original visual identity. The 1460 is Dr. Martens’ defining eight-eye boot. Introduced in 1960, it combines a rounded toe, leather upper, pull tab, yellow welt stitching, grooved sole edge, and air-cushioned outsole. It began as workwear but became a cross-generational cultural icon through music, youth subcultures, and fashion. The style is offered in numerous leathers, colors, finishes, soles, and collaboration editions.
Shoes · 1961
1461
The 1461 is the brand's classic three-eyelet shoe, introduced in 1961. It carries the same core construction language as the 1460 but in a lower-cut format suited to everyday wear, workwear, uniforms, and fashion styling. It remains one of Dr. Martens' principal products and has appeared in numerous material and color variations. The 1461 is the brand’s classic three-eyelet shoe, introduced in 1961. Its lower profile makes it suitable for workwear, schoolwear, formal-casual styling, and contemporary streetwear. Like the 1460, it is identified by the AirWair sole construction and yellow stitching, while seasonal materials and collaborations broaden its audience.
Premium footwear range · 2004
Made in England/Vintage
The Made in England or Vintage range is produced in limited quantities at the historic Cobbs Lane factory in Wollaston, Northamptonshire. It is positioned around British manufacturing heritage and construction associated with the brand's original specifications. UK output is much smaller than the company's Asian production, making this range a premium expression of Dr. Martens heritage. Made in England is the brand’s premium heritage range, produced in the United Kingdom and associated with traditional construction, specialist craftsmanship, and classic silhouettes. It preserves a connection to Dr. Martens’ Northamptonshire manufacturing history while sitting alongside the company’s larger international production network.
Alternative-material footwear · 2011
Vegan footwear
Dr. Martens' vegan line uses synthetic materials rather than conventional leather. Introduced in 2011, the range extended the brand's core silhouettes to customers seeking non-leather options and became a notable contributor to product expansion.
Clothing and accessories · 2011
Accessories and apparel
Beyond footwear, Dr. Martens sells clothing, bags, belts, and other accessories. These products extend the brand's visual language into a broader lifestyle offer and support collaborations with musicians, entertainment properties, and fashion partners.
Chelsea boot
2976
The 2976 is Dr. Martens' interpretation of the Chelsea boot, using elastic side panels and a pull tab with the brand's characteristic sole construction. It translates the brand's rugged visual identity into a comparatively streamlined ankle boot and is regularly presented in core, platform, and seasonal versions.
Platform boot
Jadon
Jadon builds on the 1460's eight-eye boot profile with a raised platform or Quad sole. The taller silhouette gives the product a more pronounced fashion presence while retaining the brand's recognizable stitching and construction details. It has become one of Dr. Martens' important contemporary icons.

Controversies

2019
Consumer concerns about product durability
Media coverage reported complaints from some customers who believed newer Dr. Martens products were less durable than older pairs. The company rejected the suggestion of a broad materials or process deterioration and stated that its defective-footwear rate was low.
Source
1999
Trademark litigation in the United States
Dr. Martens was involved in lawsuits in US courts concerning trademark rights. The company also filed additional trademark-related lawsuits in 2016.
Source

2025The Yellow Stitch
Japan
The holiday campaign centered on the 1460, 1461, and Jadon as examples of classic designs continually updated for new generations. Actor Sho Kasamatsu appeared in campaign materials, and a related live event was announced in Tokyo.
Outcome. Connected the yellow stitch signature and core products with holiday gifting, music, and Japanese cultural visibility.
Source
2023Made Strong
Global · Japan
Made Strong focused on strength, flexibility, optimism, and the ways a new generation shapes its world. Events were planned in three cities including Tokyo, and Tokyo campaign imagery featured 11 people from varied creative fields wearing contemporary Dr. Martens styles.
Outcome. Reframed the heritage proposition for contemporary self-expression and community events.
Source
2022Pride Generations
Global
A platform and video-led campaign amplified voices from LGBTQIA+ communities and addressed the brand's historical relationship with queer culture, identity, and self-expression.
Outcome. Positioned the brand as a supporter of LGBTQIA+ storytelling during Pride-related communications.
Source
20211461 Power
Japan
An Instagram campaign invited customers to share stories about confidence, individuality, and taking a step forward while wearing the 1461. Ten selected participants were offered new-season 1461 footwear.
Outcome. Generated user participation around the 1461 and the idea of personal empowerment.
Source
20212976 Power
Japan
A Japan-focused Instagram campaign asked customers to share their experiences with the 2976 under the brand's Power theme. The campaign also featured NANA MOMOSAKA and KAZANE discussing their relationships with the style.
Outcome. Extended the user-generated storytelling format from the 1461 to the 2976 Chelsea boot.
Source
2020Black Sabbath 50th-anniversary collection
Global
Dr. Martens created a footwear collection using artwork associated with Black Sabbath's first two albums, commemorating their fiftieth anniversaries and linking the brand to heavy metal heritage.
Outcome. Brand collaboration and limited product launch
Source
2019Tough As You
Global · United Kingdom · Japan
The campaign profiled artists and creators who had confronted personal or social barriers. It framed toughness as resilience and self-belief rather than merely physical durability, and featured Blaine Harrison, Nakhane Toure, Sarah Lu, and Sistren.
Outcome. Used documentary-style storytelling and portrait photography to connect the product heritage with personal resistance and inclusion.
Source
1998Football club sponsorships
United Kingdom
Dr. Martens became principal sponsor of West Ham United and sponsored Rushden & Diamonds during the late 1990s and early 2000s, including naming rights associated with stadium stands.
Outcome. Sports sponsorship activity
Source

Brand decisions

2025
Move toward a consumer-centered operating modelStrategy
Background
Management described a need to simplify the business and strengthen product-led marketing after weaker regional trading.
Action taken
The company reorganized senior management around finance, brand, operations, commercial activity, technology, customer experience, and sustainability.
Aftermath
Ije Nwokorie’s leadership began a new phase focused on consumers, product, retail execution, and operating discipline.
Source
2021
Public listingOther
Background
After years of international expansion and private-equity ownership, Dr. Martens sought access to public equity markets.
Action taken
The company listed on the London Stock Exchange under ticker DOCS.
Aftermath
Dr. Martens became a listed constituent associated with the FTSE 250 index.
Reported listing valuation. £3.7 billion (January 2021)
Source
2021
Initial public offeringM&A
Background
After several years of growth under Permira, the company sought a public-market listing.
Action taken
Dr. Martens plc listed on the London Stock Exchange premium market under DOCS.
Aftermath
The listing gave the company a public-company structure while Permira retained a substantial shareholding at the time of the offering.
IPO opening price versus offer price. £3.70 offer price → £4.54 opening price (February 2021)
Source
2014
Permira acquisitionM&A
Background
R. Griggs Group and its brand were acquired during a period when the business was being repositioned for renewed international growth.
Action taken
Permira-backed funds acquired the company for a reported £300 million.
Aftermath
The business invested in direct-to-consumer retail, e-commerce, stores, operations, and global brand management.
Acquisition value. £300 million (2014)
Source
2013
Permira acquisition of R. Griggs GroupM&A
Background
The private-equity firm acquired the company controlling the Dr. Martens brand.
Action taken
Permira purchased R. Griggs Group for a reported £300 million.
Aftermath
The brand pursued further international retail, product, and lifestyle expansion under new ownership.
Acquisition value. £300 million (October 2013)
Source
2011
Launch vegan footwearProduct launch
Background
The brand sought to broaden its customer base and provide an alternative to leather footwear.
Action taken
Dr. Martens introduced synthetic-material versions of selected boots and shoes.
Aftermath
The company and analysts attributed part of the subsequent sales growth to the vegan range.
Source
2003
Move most manufacturing to AsiaStrategy
Background
Declining sales and financial pressure led the company to close most UK factories and substantially relocate production to China and Thailand.
Action taken
The company ceased most UK shoe production, closed five factories and two shops, and retained only a small UK headquarters workforce.
Aftermath
Limited UK production returned in 2004 for the Vintage range, while the majority of production remained overseas.
Source
2003
Shift production away from most British factoriesStrategy
Background
Weakening demand and changing market conditions placed pressure on the traditional manufacturing footprint.
Action taken
Most British factories were closed and production moved mainly to China and Thailand, while a smaller Made in England operation continued.
Aftermath
The company retained a British-made premium proposition while operating a broader international manufacturing network.
Source

Recent events

Unconfirmed
Reported2026.10.09
Dr. Martens' new brand platform[17]Dr. Martens 全新品牌平台news.google.com
Dr. Martens has introduced a new brand platform, as reported by Brand Innovators.
Unconfirmed
Reported2026.09.24
Dr Martens unveils new brand platform[18]Dr Martens 推出全新品牌平台news.google.com
Dr Martens unveiled a new brand platform, as reported by FashionNetwork USA.
2021.05.20
Reported2021.05.20
Dr. Martens supports First Light Studio opening[19]Dr. Martens支持First Light Studio开幕djmag.com
First Light Studio opened in Bristol as a free-access community music studio, with the initiative supported by Dr. Martens.
2021.05.18
Reported2021.05.18
Dr. Martens releases 2021 Pride shoes[20]Dr. Martens推出2021年骄傲月鞋款thepinknews.com
Dr. Martens released a one-off Pride shoe based on its 1461 leather design, featuring rainbow details. The shoes were available on the Dr. Martens website for £119.
Unconfirmed
Reported2021.03.26
Costco offers Dr. Martens boots at a discounted price[21]好市多以优惠价格贩售马汀靴chinatimes.com
Costco offered Dr. Martens women's eight-eye boots for NT$3,399; the article reports that comparable retail-channel prices were about NT$6,000 or more and that stores saw customer rushes.
2021.02.27
Reported2021.02.27
Dr. Martens and Needles announce Chelsea boot collaboration[22]Dr. Martens与Needles宣布合作推出Chelsea靴款vman.com
Dr. Martens and Needles collaborated to rework the 2976 Chelsea boot. The article says the collaboration would be available in select Dr. Martens stores and on Dr. Martens x Needlesdrmartens.com starting February 27.
2021.02.19
Reported2021.02.19
Dr. Martens and Sanrio expand Hello Kitty collaboration[23]Dr. Martens与Sanrio扩大Hello Kitty合作licensing.biz
Dr. Martens expanded its collaborative partnership with Sanrio’s Hello Kitty brand for a new collection featuring the extended Hello Kitty and Friends character line-up on footwear.
2021.01.12
Reported2021.01.12
Dr. Martens announces Keith Haring footwear collaboration[24]Dr. Martens宣布与Keith Haring推出鞋履合作系列vman.com
Dr. Martens announced a footwear collaboration featuring Keith Haring illustrations. The range was scheduled to become available in select stores and on drmartens.com on January 22, 2021.
Unconfirmed
Reported2020.07.07
DocsCorp completes acquisition of Verowave Technologies[25]DocsCorp完成收购Verowave Technologiesfinanznachrichten.de
DocsCorp announced that it had completed acquisition agreements for Verowave Technologies, a UK provider of document production and assembly software.

Sources26 sources

Cite this profile: Cite the canonical profile. /brand-wiki/dr-martens · Editorial policy · How profiles are compiled